Panel Therapeutic Insights track
Networks or neurons: What’s next in CNS dealmaking?
Tue, Nov 10, 2026 · 9:00–9:45 AM CET Therapeutic Insights Stage, Koelnmesse
About this session
CNS remains one of the most challenging yet promising areas in drug development, attracting selective but significant investment and partnership activity. This session analyses recent deal flows, explores what's driving transactions in CNS, and examines the strategic priorities shaping partnerships between biotech innovators and larger players. With new modalities and targets emerging alongside persistent development challenges, the session discusses where value is being created and what matters most for stakeholders creating and evaluating CNS opportunities.
